Literature DB >> 21238834

Update on the characterization of Staphylococcus aureus skin infections in a pediatric dermatology tertiary health care outpatient facility: antibiotic susceptibility patterns and decreased methicillin resistance.

Melissa L Diamantis, Alex G Ortega-Loayza, Dean S Morrell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21238834     DOI: 10.1016/j.jaad.2010.06.057

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  Trends and characteristics of culture-confirmed Staphylococcus aureus infections in a large U.S. integrated health care organization.

Authors:  G Thomas Ray; Jose A Suaya; Roger Baxter
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

2.  Staphylococcus aureus Antibiotic Susceptibilities in Infections in an Outpatient Dermatology Office on O'ahu.

Authors:  Kimberly R Theos; Kory M Johnson; Douglas W Johnson
Journal:  Hawaii J Med Public Health       Date:  2019-05

3.  Antimicrobial resistance profile of Staphylococcus aureus isolates obtained from skin and soft tissue infections of outpatients from a university hospital in Recife -PE, Brazil.

Authors:  Fabiana Beserra Caraciolo; Maria Amélia Vieira Maciel; Josemir Belo dos Santos; Marcelle Aquino Rabelo; Vera Magalhães
Journal:  An Bras Dermatol       Date:  2012 Nov-Dec       Impact factor: 1.896

4.  Change in Antimicrobial Susceptibility of Skin-Colonizing Staphylococcus aureus in Korean Patients with Atopic Dermatitis during Ten-Year Period.

Authors:  Jung-Min Park; Ju-Hyun Jo; Hyunju Jin; Hyun-Chang Ko; Moon-Bum Kim; Jung-Min Kim; Do-Won Kim; Ho-Sun Jang; Byung-Soo Kim
Journal:  Ann Dermatol       Date:  2016-07-26       Impact factor: 1.444

5.  Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study.

Authors:  Gary Thomas Ray; Jose Antonio Suaya; Roger Baxter
Journal:  BMC Infect Dis       Date:  2013-05-30       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.